- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02210650
Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney
May 18, 2022 updated by: Indiana Kidney Stone Institute
Randomized Controlled Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney
Patients with a ureteral or kidney stone that causes symptoms, like pain, frequently have small kidney stones that don't cause symptoms.
If these small kidney stones are determined to be asymptomatic (not causing any problems or pain), then most urologists will simply remove the symptomatic ureteral stone and leave the additional stones in the kidneys.
However, symptomatic kidney stones started as small stones that didn't cause symptoms.
This means that the small stones remaining in the patient's kidney may cause problems later.
The purpose of our research is to test if removing small stones from the kidney prevents future stone episodes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Indiana University Health
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota
-
-
Washington
-
Seattle, Washington, United States, 98195 9472
- University of Washington Medical Center Department of Urology
-
Seattle, Washington, United States, 98195
- Veterans Administration Puget Sound Heath Care System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Scheduled to undergo surgery (URS or PCNL) for a primary stone.
- Computed tomography (CT) exam within the 90-day pre-operative period
- Small (≤ 6mm) asymptomatic stones in visible on KUB or CT (i.e., calcium stones) in the contralateral kidney for a primary renal stone or ipsilateral kidney for primary ureteral stone.
- Recurrent (having had previous stones) or multiple (simultaneous bilateral stones) stones
- Able to give informed consent
- Age 21 years or older
Exclusion Criteria:
- Inability to give informed consent
- Age less than 21 years
- Stones not visible on KUB or CT
- Patients with systemic disease or renal anatomical disorders (RTA, primary hyperparathyroidism, sarcoidosis, enteric hyperoxaluria, medullary sponge kidney)
- Any condition (eg, psychiatric illness) or situation that, in the investigator's opinion, could put the
- subject at significant risk, confound the study results, or interfere significantly with the subject's
- participation in the study.
- Unwilling to participate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Symptomatic stone removal
Group 1 will receive the standard treatment of having only the symptomatic stone removed
|
Symptomatic stone removal by the surgical procedures called Ureteroscopy or Percutaneous Nephrolithotomy
|
Other: Asymptomatic kidney stones and symptomatic stone removed
Group 2 will include the step of having the asymptomatic kidney stones removed in addition to the symptomatic stone
|
Asymptomatic kidney stones and symptomatic stone removal by the surgical procedure called Ureteroscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Relapse of stone disease on the study side
Time Frame: annually up to 5 years after stone removal surgery
|
|
annually up to 5 years after stone removal surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: James E Lingeman, MD, Indiana University Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
May 1, 2022
Study Completion (Actual)
May 1, 2022
Study Registration Dates
First Submitted
August 1, 2014
First Submitted That Met QC Criteria
August 4, 2014
First Posted (Estimate)
August 7, 2014
Study Record Updates
Last Update Posted (Actual)
May 25, 2022
Last Update Submitted That Met QC Criteria
May 18, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P01 DK 043881 Project 3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ureteral Stones, Kidney Stones
-
United States Naval Medical Center, San DiegoUnknown
-
University of British ColumbiaPercutaneous Systems, Inc.Completed
-
Adva-TecUniversity of British ColumbiaCompletedUnilateral Ureteral Stone | Renal Stone Fragments ≤ 2mmCanada
-
Robert SworWilliam Beaumont HospitalsCompletedKidney Stones | Ureteral StonesUnited States
-
Hasanuddin UniversityCompletedKidney Stones | Ureteral Stone | Ureteral StenosisIndonesia
-
Services Hospital, LahoreCompleted
-
Mansoura UniversityUnknownUrologic Diseases | Stones, Kidney | Stone, Urinary | Shock Wave LithotripsyEgypt
-
University of MichiganColoplast A/SRecruitingRenal Stone | Ureteral StoneUnited States
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingNephrolithiasis | Urolithiasis | Kidney Stones | Ureter StonesUnited States
-
Beni-Suef UniversityActive, not recruitingLower Ureteric StonesEgypt
Clinical Trials on Symptomatic stone removal
-
Centro de Educación Medica e Investigaciones Clínicas...CompletedCommon Bile Duct Stones
-
Akira HoriuchiRecruiting
-
California Pacific Medical Center Research InstituteUniversity of California, Los Angeles; Northwestern UniversityCompletedCommon Bile Duct Gall StonesUnited States
-
Hepatopancreatobiliary Surgery Institute of Gansu...Completed
-
Selcuk UniversityThe Scientific and Technological Research Council of TurkeySuspendedKidney StonesTurkey
-
Xinhua Hospital, Shanghai Jiao Tong University...Unknown
-
University Hospital, GhentEAU Young Academic Urologists Urolithiasis and Endourology Working Group; European... and other collaboratorsEnrolling by invitationNephrolithiasis | Urolithiasis | UreterolithiasisBelgium
-
EndoTheiaVanderbilt University Medical CenterEnrolling by invitation
-
Assiut UniversityCompletedPediatric Bladder StonesEgypt
-
Selcuk UniversityThe Scientific and Technological Research Council of TurkeyUnknown